[1] Kim J, Koo B K, Knoblich J A. Human organoids: model systems for human biology and medicine[J]. Nature Reviews. Molecular Cell Biology, 21, 571-584(2020).

[2] Wu W C, Li X Y, Yu S J. Patient-derived tumour organoids: a bridge between cancer biology and personalised therapy[J]. Acta Biomaterialia, 146, 23-36(2022).

[3] Li M, Izpisua Belmonte J C. Organoids: preclinical models of human disease[J]. New England Journal of Medicine, 380, 569-579(2019).

[4] Wang H X, Zhang C, Zou D L. The application of organoid models in cancer precision medicine[J]. Chinese Journal of Clinical Oncology, 50, 291-295(2023).

[5] Tebon P J, Wang B W, Markowitz A L et al. Drug screening at single-organoid resolution via bioprinting and interferometry[J]. Nature Communications, 14, 3168(2023).

[6] Lawlor K T, Vanslambrouck J M, Higgins J W et al. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation[J]. Nature Materials, 20, 260-271(2021).

[7] Sirica A E, Gores G J, Groopman J D et al. Intrahepatic cholangiocarcinoma: continuing challenges and translational advances[J]. Hepatology, 69, 1803-1815(2019).

[8] Koch M, Nickel S, Lieshout R et al. Label-free imaging analysis of patient-derived cholangiocarcinoma organoids after sorafenib treatment[J]. Cells, 11, 3613(2022).

[9] Sang C, Gao Q. Research progress and clinical implication on origin cells of intrahepatic cholangiocarcinoma[J]. Chinese Journal of Clinical Oncology, 50, 286-290(2023).

[10] Zhang N, Yang H, Wang P. Progress in the application of organoids in cancer research, drug screening, and precision diagnosis and treatment[J]. Journal of Peking University (Health Sciences), 54, 814-821(2022).

[11] Rios A C, Clevers H. Imaging organoids: a bright future ahead[J]. Nature Methods, 15, 24-26(2018).

[12] Vakoc B J, Fukumura D, Jain R K et al. Cancer imaging by optical coherence tomography: preclinical progress and clinical potential[J]. Nature Reviews Cancer, 12, 363-368(2012).

[13] Fujimoto J G, Pitris C, Boppart S A et al. Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy[J]. Neoplasia, 2, 9-25(2000).

[14] Wang N, Wang X Y, Yan T Y et al. Label-free structural and functional volumetric imaging by dual-modality optical-Raman projection tomography[J]. Science Advances, 9, eadf3504(2023).

[15] Mukherjee P, Miyazawa A, Fukuda S et al. Label-free functional and structural imaging of liver microvascular complex in mice by Jones matrix optical coherence tomography[J]. Scientific Reports, 11, 20054(2021).

[16] Deloria A J, Haider S, Dietrich B et al. Ultra-high-resolution 3D optical coherence tomography reveals inner structures of human placenta-derived trophoblast organoids[J]. IEEE Transactions on Bio-Medical Engineering, 68, 2368-2376(2021).

[17] Ming Y X, Hao S Y, Wang F et al. Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography[J]. Biosensors and Bioelectronics, 207, 114136(2022).

[18] Gil D A, Deming D A, Skala M C. Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomography[J]. Biomedical Optics Express, 12, 3789-3805(2021).

[19] Bao D, Wang L, Zhou X F et al. Automated detection and growth tracking of 3D bio-printed organoid clusters using optical coherence tomography with deep convolutional neural networks[J]. Frontiers in Bioengineering and Biotechnology, 11, 1133090(2023).

[20] Zhang L Y, Wang L, Yang S S et al. Quantifying the drug response of patient-derived organoid clusters by aggregated morphological indicators with multi-parameters based on optical coherence tomography[J]. Biomedical Optics Express, 14, 1703-1717(2023).

[21] Mukashyaka P, Kumar P, Mellert D J et al. High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology with Cellos[J]. Nature Communications, 14, 8406(2023).

[22] Yao Y, Xu X Y, Yang L F et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer[J]. Cell Stem Cell, 26, 17-26(2020).

[23] Yang J W, Zhang G, Chen X J et al. Quantitative identification of concrete surface cracks based on deep learning clustering segmentation and morphology[J]. Laser & Optoelectronics Progress, 57, 221023(2020).

[24] Hou W, Wang J F, Liu Y R. Spectral pattern recognition and traceability analysis of human fingernail based on machine learning[J]. Laser & Optoelectronics Progress, 59, 1830002(2022).

[25] Liu L X, He D, Li M Z et al. Identification of Xinjiang jujube varieties based on hyperspectral technique and machine learning[J]. Chinese Journal of Lasers, 47, 1111002(2020).

[26] Du X, Chen Z Z, Li Q W et al. Organoids revealed: morphological analysis of the profound next generation in-vitro model with artificial intelligence[J]. Bio-Design and Manufacturing, 6, 319-339(2023).

[27] Chen Z Z, Ma N, Sun X W et al. Automated evaluation of tumor spheroid behavior in 3D culture using deep learning-based recognition[J]. Biomaterials, 272, 120770(2021).

[28] Zhang S D, Li L, Yu P F et al. A deep learning model for drug screening and evaluation in bladder cancer organoids[J]. Frontiers in Oncology, 13, 1064548(2023).

[29] Hradecka L, Wiesner D, Sumbal J et al. Segmentation and tracking of mammary epithelial organoids in brightfield microscopy[J]. IEEE Transactions on Medical Imaging, 42, 281-290(2023).

[30] Abdul L, Xu J, Sotra A et al. D-CryptO: deep learning-based analysis of colon organoid morphology from brightfield images[J]. Lab on a Chip, 22, 4118-4128(2022).

[31] Mergenthaler P, Hariharan S, Pemberton J M et al. Rapid 3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning[J]. PLoS Computational Biology, 17, e1008630(2021).